Expression and immunogenic characterization of recombinant gp350 for developing a subunit vaccine against Epstein-Barr virus. Appl Microbiol Biotechnol. 2015 Oct 3

2016年01月07日 00:00 点击：[]

Wang M*, Jiang S, Han ZW, Zhao B, Wang L, Zhou ZX, Wang YF*. Expression and immunogenic characterization of recombinant gp350 for developing a subunit vaccine against Epstein-Barr virus.Appl Microbiol Biotechnol.2015 Oct 3. [Epub ahead of print]

上一条：Phosphorylation of apoptosis repressor with caspase recruitment domain by protein kinase CK2 contributes to chemotherapy resistance by inhibiting doxorubicin induced apoptosis. Oncotarget. 2015; 6:27700-27713. 下一条：TBK1 inhibitors: a review of patent literature (2011 - 2014). Expert Opin Ther Pat. 2015;21:1-12.

【关闭】